Dasatinib plus intensive chemotherapy in children, adolescents, and young adults with philadelphia chromosome–positive acute lymphoblastic leukemia: Results of children’s oncology group trial AALL0622

William B. Slayton*, Kirk R. Schultz, John A. Kairalla, Meenakshi Devidas, Xinlei Mi, Michael A. Pulsipher, Bill H. Chang, Charles Mullighan, Ilaria Iacobucci, Lewis B. Silverman, Michael J. Borowitz, Andrew J. Carroll, Nyla A. Heerema, Julie M. Gastier-Foster, Brent L. Wood, Sherri L. Mizrahy, Thomas Merchant, Valerie I. Brown, Lance Sieger, Marilyn J. SiegelElizabeth A. Raetz, Naomi J. Winick, Mignon L. Loh, William L. Carroll, Stephen P. Hunger

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

96 Scopus citations

Fingerprint

Dive into the research topics of 'Dasatinib plus intensive chemotherapy in children, adolescents, and young adults with philadelphia chromosome–positive acute lymphoblastic leukemia: Results of children’s oncology group trial AALL0622'. Together they form a unique fingerprint.

Medicine & Life Sciences